Old Web
English
Sign In
Acemap
>
authorDetail
>
David JianJun Li
David JianJun Li
Eisai
Medicine
Oncology
Clinical study design
Internal medicine
Disease
2
Papers
2
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
The Design of Dominantly Inherited Alzheimer Disease Trial of the Anti-tau Antibody, E-2814, on the DIAN-TU Tau Next Generation Platform
2021
Lon S. Schneider
Randall J. Bateman
David B. Clifford
Eric McDade
Guoqiao Wang
Jorge J Llibre-Guerra
Yan Li
Susan Mills
Anna Santacruz
Pallavi Sachdev
David JianJun Li
Stacie OSullivan
Takuya Yagi
Akihiko Koyama
Michael C. Irizarry
Larisa Reyderman
Show All
Source
Cite
Save
Citations (0)
AHEAD 3‐45 study design: A global study to evaluate the efficacy and safety of treatment with BAN2401 for 216 weeks in preclinical Alzheimer’s disease with intermediate amyloid (A3 trial) and elevated amyloid (A45 trial): Clinical trial design and implementation
2020
Alzheimers & Dementia
Paul S. Aisen
Jin Zhou
Michael C. Irizarry
Lynn D. Kramer
Chad J. Swanson
Shobha Dhadda
Martin Rabe
Stephen Krause
David JianJun Li
Rema Raman
Michael C. Donohue
Gopalan Sethuraman
Keith A. Johnson
Reisa A. Sperling
Show All
Source
Cite
Save
Citations (2)
1